Technology
Health
Biotechnology

Cue Biopharma

$7.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.18 (2.55%) As of 3:00 PM EDT today
+$0.18 (2.55%) Today

Why Robinhood?

You can buy or sell Cue Biopharma and other stocks, options, ETFs, and crypto commission-free!

About CUE

Cue Biopharma, Inc. Common Stock, also called Cue Biopharma, is a biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Read More Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded on December 31, 2014 and is headquartered in Cambridge, MA.

Employees
46
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
150.68M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
136.54K
High Today
$7.45
Low Today
$7.25
Open Price
$7.25
Volume
20.32K
52 Week High
$12.00
52 Week Low
$4.16

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2018 IPO
US
North America
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.